Literature DB >> 22033020

The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

Keertan Dheda1, Giovanni B Migliori.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22033020     DOI： 10.1016/S0140-6736(11)61062-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  Multidrug-resistant tuberculosis today.

Authors:  A Matteelli; R Centis; L D'Ambrosio; G B Migliori
Journal:  Bull World Health Organ       Date:  2012-02-01       Impact factor: 9.408

2.  Structure-Based Optimization of Pyridoxal 5'-Phosphate-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis.

Authors:  Feng Liu; Surendra Dawadi; Kimberly M Maize; Ran Dai; Sae Woong Park; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  J Med Chem       Date:  2017-06-22       Impact factor: 7.446

3.  A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.

Authors:  Alexander L Perryman; Weixuan Yu; Xin Wang; Sean Ekins; Stefano Forli; Shao-Gang Li; Joel S Freundlich; Peter J Tonge; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2015-02-17       Impact factor: 4.956

Review 4.  The medical and surgical treatment of drug-resistant tuberculosis.

Authors:  Gregory L Calligaro; Loven Moodley; Greg Symons; Keertan Dheda
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

5.  Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis.

Authors:  Sean Ekins; Allen C Casey; David Roberts; Tanya Parish; Barry A Bunin
Journal:  Tuberculosis (Edinb)       Date:  2013-12-19       Impact factor: 3.131

6.  Failing Siracusa: governments' obligations to find the least restrictive options for tuberculosis control.

Authors:  K W Todrys; E Howe; J J Amon
Journal:  Public Health Action       Date:  2013-03-21

7.  Care of the patient with XDR-TB who has failed treatment.

Authors:  Karen Blake Jacobson; Matthew Tate; Francois Eksteen; Anthony Moll; Nesri Padayatchi; Gerald Friedland; Sheela Shenoi
Journal:  Lancet Respir Med       Date:  2015-04       Impact factor: 30.700

8.  Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.

Authors:  Neel R Gandhi; Darren Weissman; Prashini Moodley; Melissa Ramathal; Inga Elson; Barry N Kreiswirth; Barun Mathema; Elena Shashkina; Richard Rothenberg; Anthony P Moll; Gerald Friedland; A Willem Sturm; N Sarita Shah
Journal:  J Infect Dis       Date:  2012-11-19       Impact factor: 5.226

Review 9.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

10.  Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Authors:  G B Migliori; G Sotgiu; N R Gandhi; D Falzon; K DeRiemer; R Centis; M G Hollm-Delgado; D Palmero; C Pérez-Guzmán; M H Vargas; L D'Ambrosio; A Spanevello; M Bauer; E D Chan; H S Schaaf; S Keshavjee; T H Holtz; D Menzies
Journal:  Eur Respir J       Date:  2012-10-11       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.